Correlations of Before and After Event Echocardiographic Parameters with Troponin and BNP in Hospitalized COVID-19 Patients With Cardiovascular Events.
作者信息
Furmanek Stephen, Salunkhe Vidyulata, Pahwa Siddharth, Samanapally Harideep, Nathala Pavani, Xu Qian, Ali Tshura, Deepti Fnu, Glynn Alex, McGuffin Trevor, Titus Derek, Farah Ian, Jones Christopher M, Ramirez Julio A, Clifford Sean P, Arnold Forest W, Kong Maiying, Roser Lynn, Huang Jiapeng
机构信息
Division of Infectious Diseases, Center of Excellence for Research in Infectious Diseases, Department of Medicine, University of Louisville, Louisville, KY; Norton Infectious Diseases Institute, Norton Healthcare, Louisville, KY.
Division of Infectious Diseases, Center of Excellence for Research in Infectious Diseases, Department of Medicine, University of Louisville, Louisville, KY.
出版信息
J Cardiothorac Vasc Anesth. 2022 Dec;36(12):4553-4555. doi: 10.1053/j.jvca.2022.08.024. Epub 2022 Sep 2.
Abstract
摘要
相似文献
1
Correlations of Before and After Event Echocardiographic Parameters with Troponin and BNP in Hospitalized COVID-19 Patients With Cardiovascular Events.
J Cardiothorac Vasc Anesth. 2022 Dec;36(12):4553-4555. doi: 10.1053/j.jvca.2022.08.024. Epub 2022 Sep 2.
2
Determining Which Hospitalized Coronavirus Disease 2019 Patients Require Urgent Echocardiography.
J Am Soc Echocardiogr. 2021 Aug;34(8):831-838. doi: 10.1016/j.echo.2021.03.010. Epub 2021 Apr 1.
3
Plasma brain natriuretic peptide, D-Dimer, and serum troponin-I as predictors for in-hospital death in patients with COVID-19.
Egypt J Immunol. 2023 Jul;30(3):32-43.
4
Clinical Significance of Increased Cardiac Troponin T in Patients with Chronic Hemodialysis and Cardiovascular Disease: Comparison to B-Type Natriuretic Peptide and A-Type Natriuretic Peptide Increase.
Kidney Blood Press Res. 2019;44(5):1050-1062. doi: 10.1159/000502232. Epub 2019 Sep 5.
5
High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.
Cardiovasc Diabetol. 2019 Dec 17;18(1):171. doi: 10.1186/s12933-019-0974-2.
6
Prognostic Value of Troponin-T and B-Type Natriuretic Peptide in Patients Hospitalized for COVID-19.
Arq Bras Cardiol. 2020 Oct;115(4):660-666. doi: 10.36660/abc.20200385.
7
High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate.
Eur Heart J. 2012 Sep;33(18):2272-81. doi: 10.1093/eurheartj/ehs163. Epub 2012 Jun 27.
8
Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide: biomarkers for mortality in a large community-based cohort free of heart failure.
Hypertension. 2006 May;47(5):874-80. doi: 10.1161/01.HYP.0000216794.24161.8c. Epub 2006 Apr 3.
9
10
High-sensitivity cardiac troponin I and B-type natriuretic Peptide as predictors of vascular events in primary prevention: impact of statin therapy.
Circulation. 2015 May 26;131(21):1851-60. doi: 10.1161/CIRCULATIONAHA.114.014522. Epub 2015 Mar 30.
引用本文的文献
1
Association between echocardiographic features, troponin levels, and survival time in hospitalized COVID-19 patients with cardiovascular events.
J Anesth Transl Med. 2024 Jun;3(2):36-44. doi: 10.1016/j.jatmed.2024.05.001. Epub 2024 May 8.
2
Different clinical characteristics and outcomes of adult hospitalized SARS-CoV-2 pneumonia patients complicated by cardiovascular events during the first, delta and omicron waves of COVID-19.
Front Epidemiol. 2024 Apr 18;4:1342917. doi: 10.3389/fepid.2024.1342917. eCollection 2024.
本文引用的文献
1
Evaluating the role of transthoracic echocardiography in hospitalised patients with COVID-19 infection.
Open Heart. 2022 May;9(1). doi: 10.1136/openhrt-2021-001854.
2
Pericardial Involvement in Patients Hospitalized With COVID-19: Prevalence, Associates, and Clinical Implications.
J Am Heart Assoc. 2022 Apr 5;11(7):e024363. doi: 10.1161/JAHA.121.024363. Epub 2022 Mar 21.
3
Electrocardiographic Features and Outcome: Correlations in 124 Hospitalized Patients With COVID-19 and Cardiovascular Events.
J Cardiothorac Vasc Anesth. 2022 Aug;36(8 Pt B):2927-2934. doi: 10.1053/j.jvca.2022.01.011. Epub 2022 Jan 13.
4
Echocardiographic 60-day mortality markers in patients hospitalized in intensive care for COVID-19.
Heart Lung. 2022 Mar-Apr;52:123-129. doi: 10.1016/j.hrtlng.2021.12.007. Epub 2022 Jan 3.
5
Outcomes and Risk Factors for Cardiovascular Events in Hospitalized COVID-19 Patients.
J Cardiothorac Vasc Anesth. 2021 Dec;35(12):3581-3593. doi: 10.1053/j.jvca.2021.03.035. Epub 2021 Mar 27.
6
Right ventricular-arterial uncoupling independently predicts survival in COVID-19 ARDS.
Crit Care. 2020 Nov 30;24(1):670. doi: 10.1186/s13054-020-03385-5.
7
Prognostic Utility of Right Ventricular Remodeling Over Conventional Risk Stratification in Patients With COVID-19.
J Am Coll Cardiol. 2020 Oct 27;76(17):1965-1977. doi: 10.1016/j.jacc.2020.08.066.
8
Echocardiographic features of patients with COVID-19 infection: a cross-sectional study.
Int J Cardiovasc Imaging. 2021 Mar;37(3):825-834. doi: 10.1007/s10554-020-02051-9. Epub 2020 Oct 8.
9
Echocardiographic findings in critical patients with COVID-19.
Rev Esp Cardiol (Engl Ed). 2020 Oct;73(10):861-863. doi: 10.1016/j.rec.2020.06.030. Epub 2020 Jul 30.
Zotero 插件